301 related articles for article (PubMed ID: 24837011)
1. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
Ding H; Sun Y; Hou Y; Li L
Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
[TBL] [Abstract][Full Text] [Related]
2. INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells.
Sun Y; Ding H; Liu X; Li X; Li L
Tumour Biol; 2014 May; 35(5):4469-77. PubMed ID: 24420152
[TBL] [Abstract][Full Text] [Related]
3. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
Li D; Yang J; Ma H; Sun C; Feng R
J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
[TBL] [Abstract][Full Text] [Related]
4. MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways.
Zhou S; Dai Z; Wang L; Gao X; Yang L; Wang Z; Wang Q; Liu Z
J Cell Mol Med; 2021 Dec; 25(24):11157-11169. PubMed ID: 34761497
[TBL] [Abstract][Full Text] [Related]
5. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells.
Chang SH; Bae JH; Hong DP; Choi KD; Kim SC; Her E; Kim SH; Kang CD
J Ethnopharmacol; 2010 Jul; 130(2):248-54. PubMed ID: 20438825
[TBL] [Abstract][Full Text] [Related]
6. INPP4B overexpression suppresses migration, invasion and angiogenesis of human prostate cancer cells.
Chen H; Li H; Chen Q
Clin Exp Pharmacol Physiol; 2017 Jun; 44(6):700-708. PubMed ID: 28261855
[TBL] [Abstract][Full Text] [Related]
7. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G
Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412
[TBL] [Abstract][Full Text] [Related]
8. Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.
Ip LR; Poulogiannis G; Viciano FC; Sasaki J; Kofuji S; Spanswick VJ; Hochhauser D; Hartley JA; Sasaki T; Gewinner CA
Oncotarget; 2015 Apr; 6(12):10548-62. PubMed ID: 25868852
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.
Cardoso HJ; Vaz CV; Correia S; Figueira MI; Marques R; Maia CJ; Socorro S
Prostate; 2015 Jun; 75(9):923-35. PubMed ID: 25786656
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
Hodgson MC; Shao LJ; Frolov A; Li R; Peterson LE; Ayala G; Ittmann MM; Weigel NL; Agoulnik IU
Cancer Res; 2011 Jan; 71(2):572-82. PubMed ID: 21224358
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of lentiviral vector-mediated SHIP gene transfection on proliferation of leukemia K562 cells and PI3K/Akt pathway regulation].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L
Ai Zheng; 2009 Apr; 28(4):366-72. PubMed ID: 19622295
[TBL] [Abstract][Full Text] [Related]
12. Doxycycline synergizes with doxorubicin to inhibit the proliferation of castration-resistant prostate cancer cells.
Zhu C; Yan X; Yu A; Wang Y
Acta Biochim Biophys Sin (Shanghai); 2017 Nov; 49(11):999-1007. PubMed ID: 28985240
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
[TBL] [Abstract][Full Text] [Related]
14. The effect of 3-aminobenzamide, inhibitor of poly(ADP-ribose) polymerase, on human osteosarcoma cells.
De Blasio A; Musmeci MT; Giuliano M; Lauricella M; Emanuele S; D'Anneo A; Vassallo B; Tesoriere G; Vento R
Int J Oncol; 2003 Dec; 23(6):1521-8. PubMed ID: 14612922
[TBL] [Abstract][Full Text] [Related]
15. Phenoxodiol inhibits growth of metastatic prostate cancer cells.
Aguero MF; Venero M; Brown DM; Smulson ME; Espinoza LA
Prostate; 2010 Aug; 70(11):1211-21. PubMed ID: 20564423
[TBL] [Abstract][Full Text] [Related]
16. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C
Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522
[TBL] [Abstract][Full Text] [Related]
17. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
18. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
Lee SH; Kang YJ; Sung B; Kim DH; Lim HS; Kim HR; Kim SJ; Yoon JH; Moon HR; Chung HY; Kim ND
Int J Oncol; 2014 Mar; 44(3):905-11. PubMed ID: 24424889
[TBL] [Abstract][Full Text] [Related]
19. A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3.
Shi M; Zhou X; Zhang Z; Wang M; Chen G; Han K; Cao B; Liu Z; Mao X
Toxicol Lett; 2014 Aug; 228(3):133-9. PubMed ID: 24831963
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
Sun Y; Zhou L; Lv D; Liu H; He T; Wang X
Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):422-30. PubMed ID: 25926140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
